Hypoparathyroidism and assisted reproductive technology: considerations while undergoing ovarian hyperstimulation
Hypoparathyroidism (hypoPTH) is a rare disease that requires diligent adherence to treatment regimens to prevent hypocalcemia but also treatment-induced hypercalcemia and hypercalciuria. The menstrual cycle, pregnancy, and lactation can all impact calcium homeostasis but there is little known regard...
Saved in:
| Published in | Current opinion in endocrinology, diabetes, and obesity |
|---|---|
| Main Authors | , , |
| Format | Journal Article |
| Language | English |
| Published |
England
18.09.2024
|
| Online Access | Get more information |
Cover
Loading…
| Summary: | Hypoparathyroidism (hypoPTH) is a rare disease that requires diligent adherence to treatment regimens to prevent hypocalcemia but also treatment-induced hypercalcemia and hypercalciuria. The menstrual cycle, pregnancy, and lactation can all impact calcium homeostasis but there is little known regarding the impact of ovarian stimulation. Furthermore, the limited reports suggest no clear association between menstrual phase and calcium balance among those with hypoPTH. With increasing patient utilization of assisted reproductive technology (ART), there is a need for better understanding the care required for patients with hypoparathyroidism pursuing fertility technology.
There is currently no literature available on patients with hypoparathyroidism and the impact of controlled ovarian stimulation on calcium homeostasis. We present information regarding physiologic changes in pregnancy that impact calcium homeostasis and the first case presentation of a patient with hypoparathyroidism pursuing ART.
This article provides the first insights and guidance when providing fertility care for patients with hypoparathyroidism. |
|---|---|
| ISSN: | 1752-2978 |
| DOI: | 10.1097/MED.0000000000000887 |